CIK 0001357459
- Non-accelerated filer
- Smaller reporting company
PALISADE BIO, INC.
Sign in to watch- Ticker
- PALI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 522007292
- Phone
- +1 858-704-4900
- Business address
- 7750 EL CAMINO REAL, SUITE 5200, CARLSBAD, CA, 92009
- Former names
- PALISADE BIO, INC., Seneca Biopharma, Inc., Neuralstem, Inc.
- Open-market buys, last 90 days
- $28,800
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$28,800. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 87 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-07-01 | OGILVIE SCOTT VARDE Director | Grant or award | +53,476 | 86,020 | ||
| 2015-07-01 | OGILVIE SCOTT VARDE Director | Grant or award · Common Stock Purchase Option | +99,824 | 99,824 | ||
| 2015-07-01 | WESTREICH STANLEY Director | Grant or award | +106,952 | 1,564,854 | ||
| 2015-07-01 | Sohn Catherine A. Director | Grant or award | +106,952 | 106,952 | ||
| 2015-07-01 | SMITH SANDFORD D Director | Grant or award | +106,952 | 106,952 | ||
| 2015-07-01 | OLDAKER WILLIAM CLYDE Director | Grant or award | +53,476 | 181,826 | ||
| 2015-07-01 | OLDAKER WILLIAM CLYDE Director | Grant or award · Common Stock Purchase Option | +99,824 | 99,824 | ||
| 2015-05-27 | OLDAKER WILLIAM CLYDE Director | Option exercise | +60,000 | $1.32 | $79K | 176,939 |
| 2015-05-27 | OLDAKER WILLIAM CLYDE Director | Shares withheld for taxes | −48,589 | $1.63 | $79K | 128,350 |
| 2015-05-27 | OLDAKER WILLIAM CLYDE Director | Option exercise · Common Stock purchase option | −60,000 | 0 | ||
| 2015-05-22 | OGILVIE SCOTT VARDE Director | Option exercise | +60,000 | $1.32 | $79K | 80,837 |
| 2015-05-22 | OGILVIE SCOTT VARDE Director | Shares withheld for taxes | −48,293 | $1.64 | $79K | 32,544 |
| 2015-05-22 | OGILVIE SCOTT VARDE Director | Option exercise · Common Stock purchase option | −60,000 | 0 | ||
| 2015-04-17 | JOHE KARL Chief Scientific Officer | Gift | −6,800 | 488,947 | ||
| 2015-03-03 | GARR RICHARD CEO | Gift | −5,000 | 235,000 | ||
| 2015-02-20 | JOHE KARL Chief Scientific Officer | Grant or award · Common Stock Purchase Option | +315,126 | 315,126 | ||
| 2015-02-20 | GARR RICHARD CEO | Grant or award · Common Stock Purchase Option | +171,008 | 171,008 | ||
| 2014-12-18 | GARR RICHARD CEO | Gift | −5,000 | 1,095,337 | ||
| 2014-12-18 | GARR RICHARD CEO | Gift | −5,000 | 1,090,337 | ||
| 2014-12-18 | GARR RICHARD CEO | Gift | −7,000 | 1,083,337 |
Page 20 of 21 · 409 trades